Pfizer 2015 Annual Report Download - page 134
Download and view the complete annual report
Please find page 134 of the 2015 Pfizer annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.-
1 -
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20
-
21
-
22
-
23
-
24
-
25
-
26
-
27
-
28
-
29
-
30
-
31
-
32
-
33
-
34
-
35
-
36
-
37
-
38
-
39
-
40
-
41
-
42
-
43
-
44
-
45
-
46
-
47
-
48
-
49
-
50
-
51
-
52
-
53
-
54
-
55
-
56
-
57
-
58
-
59
-
60
-
61
-
62
-
63
-
64
-
65
-
66
-
67
-
68
-
69
-
70
-
71
-
72
-
73
-
74
-
75
-
76
-
77
-
78
-
79
-
80
-
81
-
82
-
83
-
84
-
85
-
86
-
87
-
88
-
89
-
90
-
91
-
92
-
93
-
94
-
95
-
96
-
97
-
98
-
99
-
100
-
101
-
102
-
103
-
104
-
105
-
106
-
107
-
108
-
109
-
110
-
111
-
112
-
113
-
114
-
115
-
116
-
117
-
118
-
119
-
120
-
121
-
122
-
123
-
124 -
125 -
126 -
127 -
128 -
129 -
130 -
131 -
132 -
133 -
134
 |
 |
Peer Group Performance Graph
Pfizer Inc. and Subsidiary Companies
2015 Financial Report 133
The following graph assumes a $100 investment on December 31, 2010, and reinvestment of all dividends, in each of the Company’s
Common Shares, the S&P 500 Index, and a composite peer group of the major U.S.- and European-based pharmaceutical companies, which
are: Abbott Laboratories (for the period 2010-2012 only), AbbVie Inc. (for 2013, 2014 and 2015 only), Amgen, Inc., AstraZeneca plc, Bristol-
Myers Squibb Company, Eli Lilly & Co., GlaxoSmithKline plc, Johnson & Johnson, Merck and Co., Inc., Novartis AG, Roche Holding AG and
Sanofi SA.
Five Year Performance
2010 2011 2012 2013 2014 2015
PFIZER $100.0 $128.8 $155.1 195.7 $206.1 $220.7
PEER GROUP $100.0 $115.0 $129.2 171.8 $193.2 $196.0
S&P 500 $100.0 $102.1 $118.4 156.8 $178.2 $180.7
$50
$75
$100
$125
$150
$175
$200
$225
$250
2010 2011 2012 2013 2014 2015
PFIZER PEER GROUP S&P 500